Mizukami Kazuhiro, Fushimi Erina, Sagami Ryota, Abe Takashi, Sato Takao, Terashi Shohei, Fukuda Masahide, Nishikiori Hidefumi, Nagai Takayuki, Kodama Masaaki, Murakami Kazunari
Department of Gastroenterology, Faculty of Medicine, Oita University, 1-1, Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan.
Department of Gastroenterology, Oita San-ai Medical Center, 1213 Ichi, Oita 870-1151, Japan.
J Clin Med. 2023 Oct 2;12(19):6332. doi: 10.3390/jcm12196332.
In the present prospective case series study, we investigated the lesion-detection ability of an AI-equipped colonoscopy as an addition to colonoscopy (CS) screening. Participants were 100 patients aged ≥20 years who had not undergone CS at the study site in the last 3 years and passed the exclusion criteria. CS procedures were conducted using conventional white light imaging and computer-aided detection (CADe). Adenoma detection rate (ADR; number of individuals with at least one adenoma detected) was compared between the conventional group and the CADe group. Of the 170 lesions identified, the ADR of the CADe group was significantly higher than the ADR of the conventional group (69% vs. 61%, = 0.008). For the expert endoscopists, although ADR did not differ significantly, the mean number of detected adenomas per procedure (MAP) was significantly higher in the CADe group than in the conventional group (1.7 vs. 1.45, = 0.034). For non-expert endoscopists, ADR and MAP were significantly higher in the CADe group than in the conventional group (ADR 69.5% vs. 56.6%, = 0.016; MAP 1.66 vs. 1.11, < 0.001). These results indicate that the CADe function in CS screening has a positive effect on adenoma detection, especially for non-experts.
在本前瞻性病例系列研究中,我们调查了配备人工智能的结肠镜检查作为结肠镜(CS)筛查补充手段的病变检测能力。研究对象为100名年龄≥20岁、过去3年未在研究地点接受过CS检查且通过排除标准的患者。CS检查采用传统白光成像和计算机辅助检测(CADe)进行。比较了传统组和CADe组的腺瘤检出率(ADR;检测到至少一个腺瘤的个体数量)。在识别出的170个病变中,CADe组的ADR显著高于传统组(69%对61%,P = 0.008)。对于专家内镜医师,虽然ADR无显著差异,但CADe组每次检查的平均腺瘤检出数(MAP)显著高于传统组(1.7对1.45,P = 0.034)。对于非专家内镜医师,CADe组的ADR和MAP显著高于传统组(ADR 69.5%对56.6%,P = 0.016;MAP 1.66对1.11,P < 0.001)。这些结果表明,CS筛查中的CADe功能对腺瘤检测有积极作用,尤其是对非专家而言。